We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AURA market cap is 453.4M. The company's latest EPS is USD -1.5403 and P/E is -5.97.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.32M | -20.49M | -24.78M | -22.31M | -22.76M |
| Net Income | -18.3M | -18.51M | -22.13M | -19.71M | -20.34M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -35.25M | -60.3M | -84.99M |
| Net Income | -35.25M | -58.76M | -76.41M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 192.74M | 179.77M | 255.08M | 235.03M | 218.28M |
| Total Liabilities | 26.3M | 28.05M | 29.23M | 26.24M | 26.83M |
| Total Equity | 166.44M | 151.72M | 225.85M | 208.78M | 191.45M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 160.03M | 223.94M | 255.08M |
| Total Liabilities | 7.72M | 28.35M | 29.23M |
| Total Equity | 152.32M | 195.58M | 225.85M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -31.06M | -46.46M | -63.85M | -24.45M | -40.58M |
| Investing | -45.47M | -23.84M | -113.96M | 9.4M | 29.24M |
| Financing | 2.68M | 4.31M | 97.29M | 253k | 336k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.41M | -54.6M | -63.85M |
| Investing | -2.13M | -67.87M | -113.96M |
| Financing | 166.26M | 95.63M | 97.29M |
| Market Cap | 453.4M |
| Price to Earnings Ratio | -5.97 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.11 |
| Price to Book Ratio | 2.02 |
| Dividend Yield | - |
| Shares Outstanding | 49.61M |
| Average Volume (1 week) | 161.14k |
| Average Volume (1 Month) | 180.54k |
| 52 Week Change | 11.87% |
| 52 Week High | 12.3782 |
| 52 Week Low | 6.63 |
| Spread (Intraday) | 0.63 (6.57%) |
| Company Name | Aura Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.aurabiosciences.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
